IBM Quantum Helps Advance Healthcare and Biology Research

Quantum computing is enabling new breakthroughs in drug discovery, genomics, and biochemistry through the Wellcome Leap Q4Bio Challenge.

Apr. 16, 2026 at 6:53pm

Got story updates? Submit your updates here. ›

A highly structured abstract painting in soft, flat colors featuring sweeping geometric arcs, concentric circles, and precise botanical spirals, conveying the complex structural order of quantum computing algorithms and their potential impact on scientific research.Quantum computing breakthroughs are accelerating progress in healthcare and biology research, as demonstrated by the ambitious projects showcased in the Q4Bio Challenge.Chicago Today

In the first ever Q4Bio Challenge, research teams sought to demonstrate scalable quantum algorithms for healthcare, with Algorithmiq's work alongside Cleveland Clinic and IBM earning the $2 million grand prize. Five of the six finalist teams used IBM quantum hardware for their research, showcasing how quantum computing is becoming a practical tool for solving real-world problems in fields like biology and medicine.

Why it matters

The Q4Bio challenge results highlight the rapid progress of quantum computing and its growing potential to support meaningful research in healthcare and the life sciences. By working directly with today's most capable quantum hardware, these multidisciplinary teams were able to tackle complex problems at significant scale, paving the way for future quantum advantage in areas like drug discovery, genomics, and biochemistry.

The details

The winning project, led by quantum startup Algorithmiq in collaboration with Cleveland Clinic and IBM, used quantum computing to simulate key processes in photodynamic cancer therapy. Other finalists tackled challenges in areas like genome encoding, biomarker discovery, and modeling of fundamental biochemical reactions. All of the teams leveraged IBM's quantum hardware, including systems with over 100 qubits, to run large-scale demonstrations that exceeded the capabilities of classical computers.

  • The Q4Bio Challenge was launched in 2023 with $40 million in funding.
  • By March 2026, the program had narrowed to six Phase III finalists.
  • The winners were announced in April 2026.

The players

Algorithmiq

A quantum startup that collaborated with Cleveland Clinic and IBM on the winning project.

Cleveland Clinic

A leading healthcare organization that partnered with Algorithmiq and IBM on the winning project.

IBM

A leading provider of quantum computing hardware and software that supported the research efforts of multiple Q4Bio finalists.

Wellcome Leap

A non-profit organization that established the Q4Bio Supported Challenge Program to accelerate the development of quantum algorithms for healthcare.

University of Oxford and Sanger Institute

A team that focused on converting genome problems to quantum optimization formulations.

Got photos? Submit your photos here. ›

What they’re saying

“This work provides one of the clearest indications to date that quantum computing can begin to impact real, chemically relevant problems, rather than simplified benchmarks.”

— Sabrina Maniscalco, CEO and co-founder of Algorithmiq

“Encoding a whole genome onto a quantum computer is a world first and represents at least one order of magnitude improvement over any other efforts to represent DNA on quantum machines.”

— James McCafferty, Chief Information Officer at the Wellcome Sanger Institute

“Our work has already identified novel cancer biomarkers for clinical evaluation, and future quantum machines will allow us to discover even more promising biomarkers that we hope will improve treatment outcomes.”

— Fred Chong, Professor at University of Chicago and Chief Scientist for Quantum Software at Infleqtion

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

The impressive results from the Q4Bio Challenge finalists demonstrate the rapid progress of quantum computing and its growing potential to support meaningful research in healthcare and the life sciences. By leveraging IBM's quantum hardware, these multidisciplinary teams were able to tackle complex problems at significant scale, paving the way for future quantum advantage in areas like drug discovery, genomics, and biochemistry.